Company Update: Merck & Co Inc (NYSE:MRK) – Merck Serono Awards Innovation Cup and € 10,000 to Team Oncology for their Innovative Approach to Antibody-Drug Conjugates

[at noodls] – News Release Amber Chase +1 – 774-257-8629 August 7, 2014  Merck Serono Innovation Cup 2014 awards novel idea for an innovative approach to antibody-drug conjugates that may fight cancer . . . → Read More: Company Update: Merck & Co Inc (NYSE:MRK) – Merck Serono Awards Innovation Cup and € 10,000 to Team Oncology for their Innovative Approach to Antibody-Drug Conjugates Similar Articles: Company Update (NYSE:MRK): Merck Announces Third-Quarter 2014 Dividend Merck & Co Inc (NYSE:MRK) – Merck Animal Health Announces FDA Approval of BRAVECTO™ (fluralaner) Market Update: Merck & Co Inc (NYSE:MRK) – Merck to Hold Investor Briefing at Boston Research Facility